Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum

Lysophosphatidic acid (LPA) is present during the medical condition of ovarian cancer at all stages of the disease, and, therefore possesses considerable potential as a biomarker for screening its presence in female patients. Unfortunately, there is currently no clinically employable assay for this...

Descripción completa

Detalles Bibliográficos
Autores principales: De La Franier, Brian, Thompson, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168251/
https://www.ncbi.nlm.nih.gov/pubmed/32075013
http://dx.doi.org/10.3390/bios10020013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168251/
https://www.ncbi.nlm.nih.gov/pubmed/32075013
http://dx.doi.org/10.3390/bios10020013

Ejemplares similares